• Publications
  • Influence
Third universal definition of myocardial infarction.
ACCF : American College of Cardiology Foundation ACS : acute coronary syndrome AHA : American Heart Association CAD : coronary artery disease CABG : coronary artery bypass grafting CKMB : creatineExpand
  • 4,389
  • 225
  • PDF
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Jeffrey L. Anderson, MD, FACC, FAHA, Chair; Alice K. Jacobs, MD, FACC, FAHA, Immediate Past Chair[‡‡][1]; Jonathan L. Halperin, MD, FACC, FAHA, Chair-Elect; Nancy M. Albert, PhD, CCNS, CCRN, FAHA;Expand
  • 8,626
  • 214
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
WRITING COMMITTEE MEMBERS* Clyde W. Yancy, MD, MSc, FACC, FAHA, Chairyz; Mariell Jessup, MD, FACC, FAHA, Vice Chair*y; Biykem Bozkurt, MD, PhD, FACC, FAHAy; Javed Butler, MBBS, FACC, FAHA*y; DonaldExpand
  • 2,219
  • 103
  • PDF
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
The medical profession should play a central role in evaluating the evidence related to drugs, …
  • 2,950
  • 77
  • PDF
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
The utility of aminoterminal pro-brain natriuretic peptide (NT-proBNP) testing in the emergency department to rule out acute congestive heart failure (CHF) and the optimal cutpoints for this use areExpand
  • 1,059
  • 32
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Background— Fibroblast growth factor 23 (FGF-23) is a phosphorus-regulating hormone. In chronic kidney disease (CKD), circulating FGF-23 levels are markedly elevated and independently associated withExpand
  • 682
  • 31
  • PDF
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Background—Because cancer patients survive longer, the impact of cardiotoxicity associated with the use of cancer treatments escalates. The present study investigates whether early alterations ofExpand
  • 510
  • 30
  • PDF
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
Background Triple antithrombotic therapy with warfarin plus two antiplatelet agents is the standard of care after percutaneous coronary intervention (PCI) for patients with atrial fibrillation, butExpand
  • 503
  • 29
  • PDF
Third universal definition of myocardial infarction.
Authors/Task Force Members Chairpersons: Kristian Thygesen(Denmark)*, Joseph S. Alpert, (USA)*, Harvey D. White, (New Zealand)*, Biomarker Subcommittee: Allan S. Jaffe (USA), Hugo A. Katus (Germany),Expand
  • 368
  • 28
  • PDF
Myocardial Injury and Ventricular Dysfunction Related to Training Levels Among Nonelite Participants in the Boston Marathon
Background— Multiple studies have individually documented cardiac dysfunction and biochemical evidence of cardiac injury after endurance sports; however, convincing associations between the two areExpand
  • 432
  • 22